[225Ac]Ac AKY-1189

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name[225Ac]Ac AKY-1189
Drug Alias NameAKY-1189[225Ac]Ac-AKY-1189225Ac-AKY-1189
ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs +[4] 
Mechanisms of ActionNectin-4 modulatorsIonising radiation emitters
TargetsNectin-4
Therapy Area/IndicationsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAktis Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAktis Oncology Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A